UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047353
Receipt number R000054009
Scientific Title A randomized controlled trial comparing conventional ESD versus Spray-ESD for gastric neoplasms: A multi-center trial (Spray-G Trial)
Date of disclosure of the study information 2022/04/01
Last modified on 2024/04/03 08:14:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized controlled trial comparing conventional ESD versus Spray-ESD for gastric neoplasms: A multi-center trial (Spray-G Trial)

Acronym

Spray-G Trial

Scientific Title

A randomized controlled trial comparing conventional ESD versus Spray-ESD for gastric neoplasms: A multi-center trial (Spray-G Trial)

Scientific Title:Acronym

Spray-G Trial

Region

Japan


Condition

Condition

Gastric cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy of Spray mode in ESD for gastric neoplasms

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Completion of ESD with endo-knife alone

Key secondary outcomes

Number of hemostasis, time of hemostasis, treatment time (total, mucosal incision, submucosal dissection), dissection speed, en bloc resection, complete resection, curative resection (degree of each endoscopic cure), thickness and thermal degeneration of submucosal layer in resected specimen, type and volume of submucosal injective solution used, operator change, traction use, complication


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Conventional ESD(ESD with Forced Coagulation Mode)

Interventions/Control_2

Spray-ESD (ESD with Spray Coagulation Mode)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1)Presence of EGN diagnosed by endoscopy and capable of undergoing ESD as a local treatment
(2)Lesions diagnosed by endoscopic biopsy as gastric adenomas or adenocarcinomas
(3)20 years old or more
(4)Performance Status: 0, 1, 2
(5)Informed consent is obtained

Key exclusion criteria

(1)History of gastric surgery
(2)Currently undergoing dialysis
(3)Requiring continuous administration of heparin during the perioperative period.
(4)Those with contraindications for endoscopy
(5)Patients judged to be inappropriate for the study by the attending physician in this trial

Target sample size

130


Research contact person

Name of lead principal investigator

1st name Yorinobu
Middle name
Last name Sumida

Organization

Kitakyushu Municipal Medical Center

Division name

Department of Gastroenterology

Zip code

802-8561

Address

2-1-1, Bashaku, Kokura-kitaku, Kitakyushu

TEL

093-541-1831

Email

y.raisin@gmail.com


Public contact

Name of contact person

1st name Yorinobu
Middle name
Last name Sumida

Organization

Kitakyushu Municipal Medical Center

Division name

Department of Gastroenterology

Zip code

802-8561

Address

2-1-1, Bashaku, Kokura-kitaku, Kitakyushu

TEL

093-541-1831

Homepage URL


Email

y.raisin@gmail.com


Sponsor or person

Institute

Kitakyushu Municipal Medical Center

Institute

Department

Personal name



Funding Source

Organization

Kyushu University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of Kitakyushu City Hospita Organization

Address

1-35, Kofunabemachi, Kokurakita-ku, Kitakyushu City

Tel

093-533-5615

Email

kcho-kenkyu01@kitakyu-cho.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

130

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 02 Month 28 Day

Date of IRB

2022 Year 03 Month 24 Day

Anticipated trial start date

2022 Year 04 Month 04 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 04 Month 01 Day

Last modified on

2024 Year 04 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054009


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name